Zoledronic Acid Outcomes Reported in Ivorian Prostate Cancer Cohort
A retrospective cohort of 144 men in Côte d'Ivoire found that 20.8 percent of patients with metastatic castration-resistant prostate cancer ...
A retrospective cohort of 144 men in Côte d'Ivoire found that 20.8 percent of patients with metastatic castration-resistant prostate cancer ...
A Phase 1 trial presented at ESMO 2026 reports a 40% objective response rate at 130 mg for ISM6331, a ...
A phase 3 trial shows sacituzumab tirumotecan significantly lowers the risk of cancer progression and death in women with recurrent ...
A prospective cohort evaluation of 138 foundation doctors found that a one-hour tutorial was followed by higher reported oncology history-taking ...
Newsweek’s 2027 hospital ranking placed Gustave Roussy third worldwide based on professional surveys, accreditations, and patient-reported outcome measures.
An edited multidisciplinary volume reviews heterocyclic scaffolds, evaluation methods, emerging drug-design approaches and translational challenges in anticancer research.
A retrospective cohort of 269 breast cancer patients found that GLP-1 receptor agonists produced significant but markedly attenuated weight loss ...
A retrospective study of 2,409 patients found that baseline beta-1 selective beta-blocker therapy was independently associated with higher all-cause mortality, ...
A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...
An ancillary analysis of the Japanese phase III trial JCOG1013 found that a tumor proportion score of at least 1% ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine